Hepatitis B surface antigen (HBsAg) prevalence in Iraq
Iraq: Hepatitis B surface antigen (HBsAg) prevalence was 0.4% in 2024. ▼ Falling
Latest (2024)
0.4%
Change on year
down 20.0%
World rank
62nd
of 194 countries
All-time high
0.8%
in 2015
All-time low
0.4%
in 2024
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Iraq, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Iraq recorded 0.4% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
The figure is down 20.0% on the previous year and down 50.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Iraq peaked at 0.8% in 2015 and was at its lowest, 0.4%, in 2024.
That places Iraq 62nd out of 194 countries with data for 2024, putting it in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Iraq, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.8% | — |
| 2016 | 0.8% | +0.0% |
| 2017 | 0.8% | +0.0% |
| 2018 | 0.8% | +0.0% |
| 2019 | 0.7% | -12.5% |
| 2020 | 0.7% | +0.0% |
| 2021 | 0.6% | -14.3% |
| 2022 | 0.5% | -16.7% |
| 2023 | 0.5% | +0.0% |
| 2024 | 0.4% | -20.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.8% | 0.7% | 0.8% | 5 |
| 2020s | 0.5% | 0.4% | 0.7% | 5 |
Countries ranked near Iraq
- 59 Yemen 0.5% compare
- 59 Cyprus 0.5% compare
- 59 Eritrea 0.5% compare
- 62 Senegal 0.4% compare
- 62 Tanzania, United Republic of 0.4% compare
- 62 Samoa 0.4% compare
- 62 Zambia 0.4% compare
- 62 Burundi 0.4% compare
- 62 Bangladesh 0.4% compare
- 62 Cambodia 0.4% compare
- 62 Democratic People’s Republic of Korea 0.4% compare
More health data for Iraq
- Un projection of annual infant deaths, annual growth rate -1.4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9773 % change on previous year (2090)
- Heat deaths vs projected death rates 898.9 (2090)
- Un projection of annual infant deaths 5,830 (2100)
- Population ages 65 and above, total, annual growth rate 3.17 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.0345 units per person (2025)
- Population, female, annual growth rate 2.08 % change on previous year (2025)
- Population, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population, female, per capita 0.4978 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Iraq?
- Hepatitis b surface antigen (hbsag) prevalence in Iraq was 0.4% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Iraq?
- The highest recorded value was 0.8% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Iraq?
- The lowest recorded value was 0.4% in 2024.
- How does Iraq rank for hepatitis b surface antigen (hbsag) prevalence?
- Iraq ranks 62nd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Iraq?
- Over the last ten years it is down 50.0%. The long-run trend across the full record is falling.
- Where does this Iraq data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).